Royan Institute findings highlight MSCs’ potential for cell-based ASD therapy

TEHRAN – Researchers from Royan Institute, in a study, have managed to lower the Childhood Autism Rating Scale (CARS) scores and certain inflammatory biomarkers in children with autism spectrum disorder (ASD) using allogeneic mesenchymal stromal cells (MSCs) derived from umbilical cord Wharton’s jelly.